Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?

Prateek Bahl, Con Doolan, Charitha de Silva, Abrar Ahmad Chughtai, Lydia Bourouiba, C Raina MacIntyre, Prateek Bahl, Con Doolan, Charitha de Silva, Abrar Ahmad Chughtai, Lydia Bourouiba, C Raina MacIntyre

Abstract

Cases of coronavirus disease 2019 (COVID-19) have been reported in more than 200 countries. Thousands of health workers have been infected, and outbreaks have occurred in hospitals, aged care facilities, and prisons. The World Health Organization (WHO) has issued guidelines for contact and droplet precautions for healthcare workers caring for suspected COVID-19 patients, whereas the US Centers for Disease Control and Prevention (CDC) has initially recommended airborne precautions. The 1- to 2-meter (≈3-6 feet) rule of spatial separation is central to droplet precautions and assumes that large droplets do not travel further than 2 meters (≈6 feet). We aimed to review the evidence for horizontal distance traveled by droplets and the guidelines issued by the WHO, CDC, and European Centre for Disease Prevention and Control on respiratory protection for COVID-19. We found that the evidence base for current guidelines is sparse, and the available data do not support the 1- to 2-meter (≈3-6 feet) rule of spatial separation. Of 10 studies on horizontal droplet distance, 8 showed droplets travel more than 2 meters (≈6 feet), in some cases up to 8 meters (≈26 feet). Several studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) support aerosol transmission, and 1 study documented virus at a distance of 4 meters (≈13 feet) from the patient. Moreover, evidence suggests that infections cannot neatly be separated into the dichotomy of droplet versus airborne transmission routes. Available studies also show that SARS-CoV-2 can be detected in the air, and remain viable 3 hours after aerosolization. The weight of combined evidence supports airborne precautions for the occupational health and safety of health workers treating patients with COVID-19.

Keywords: COVID-19; airborne transmission; droplet precautions; mask; respiratory protection.

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Flow diagram of literature search.
Figure 2.
Figure 2.
Extent of horizontal spread of droplets. Note that direct visualization of 8 meters also appears in [35]. E, experimental studies; H, human subjects; M, modeling (mathematical or numerical) studies.

References

    1. World Health Organization. Rolling updates on coronavirus disease (COVID-19). [cited 2020 April 14] Available at: . Accessed 14 April 2020.
    1. World Health Organization. Novel coronavirus (2019-nCoV) situation reports. [cited 2020 January 31] Available at: . Accessed 31 January 2020.
    1. Wölfel R, Corman VM, Guggemos W, et al. . Virological assessment of hospitalized patients with COVID-2019. Nature 2020. doi:
    1. Li Q, Guan X, Wu P, et al. . Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020. doi:
    1. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020; 27. doi:
    1. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis. Int J Infect Dis 2020; 93:201–4.
    1. Lipsitch M, Cohen T, Cooper B, et al. . Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300:1966–70.
    1. Sepkowitz KA, Eisenberg L. Occupational deaths among healthcare workers. Emerg Infect Dis 2005; 11:1003–8.
    1. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance. [cited 2020 January 26] Available at: . Accessed 26 January 2020.
    1. World Health Organization. Management of ill travellers at points of entry - international airports, seaports and ground crossings - in the context of COVID-19 outbreak: interim guidance. [cited 16 February 2020 ] Available at: . Accessed 16 February 2020.
    1. MacIntyre CR, Zhang Y, Chughtai AA, et al. . Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness. BMJ Open 2016; 6:e012330.
    1. Centers for Disease Control and Prevention. Interim healthcare infection prevention and control recommendations for patients under investigation for 2019 novel coronavirus. [cited 2020 January 31] Available at: . Accessed 31 January 2020.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.
    1. Zhu SW, Kato S, Yang JH. Study on transport characteristics of saliva droplets produced by coughing in a calm indoor environment. Build Environ 2006; 41:1691–702.
    1. Xie X, Li Y, Chwang AT, Ho PL, Seto WH. How far droplets can move in indoor environments–revisiting the Wells evaporation-falling curve. Indoor Air 2007; 17:211–25.
    1. Parienta D, Morawska L, Johnson GR, et al. . Theoretical analysis of the motion and evaporation of exhaled respiratory droplets of mixed composition. J Aerosol Sci 2011; 42:1–10.
    1. Bourouiba L, Dehandschoewercker E, Bush JWM. Violent expiratory events: on coughing and sneezing. J Fluid Mech 2014; 745:537–63.
    1. Wei J, Li Y. Enhanced spread of expiratory droplets by turbulence in a cough jet. Build Environ 2015; 93:86–96.
    1. Bourouiba L. A sneeze. N Engl J Med 2016; 375:e15.
    1. Liu L, Wei J, Li Y, Ooi A. Evaporation and dispersion of respiratory droplets from coughing. Indoor Air 2017; 27:179–90.
    1. Lee J, Yoo D, Ryu S, et al. . Quantity, size distribution, and characteristics of cough-generated aerosol produced by patients with an upper respiratory tract infection. Aerosol Air Qual Res 2019; 19:840–53.
    1. Wei J, Li Y. Human cough as a two-stage jet and its role in particle transport. PLoS One 2017; 12:1–15.
    1. Jennison MW. Atomizing of mouth and nose secretions into the air as revealed by high-speed photography. Aerobiology. 17th ed. Washington: American Association for the Advancement of Science, 1942: pp 106–28.
    1. Centers for Disease Control and Prevention. Interim domestic guidance on the use of respirators to prevent transmission of SARS. Available at: . Accessed 11 April 2020.
    1. World Health Organization. Hospital infection control guidance for severe acute respiratory syndrome (SARS). Available at: . Accessed 11 April 2020.
    1. World Health Organization. Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: interim guidance: updated October 2019. Available at: . Accessed 11 April 2020.
    1. Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). Available at: . Accessed 11 April 2020.
    1. European Centre for Disease Control and Prevention. Rapid risk assessment: severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Available at: . Accessed 11 April 2020.
    1. Jenco M. CDC updates guidance on PPE for health care personnel; COVID-19 declared a pandemic. Available at: . Accessed 11 April 2020.
    1. Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. Available at: . Accessed 11 April 2020.
    1. European Centre for Disease Control and Prevention. Infection prevention and control and preparedness for COVID-19 in healthcare settings - second update. [cited 2020 April 11] Available at: . Accessed 11 April 2020.
    1. Yu ITSS, Li Y, Wong TW, et al. . Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004; 350:1731–9.
    1. Doremalen N van, Bushmaker T, Morris DH, et al. . Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020. doi:
    1. Leung NHL, Chu DKW, Shiu EYC, et al. . Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020. doi:
    1. Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions. JAMA 2020. doi:
    1. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35:S65–S164.
    1. Wells WF. On air-borne infection. II. Droplets and droplet nuclei. Am J Hyg 1934; 20:611–8.
    1. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. WHO Guidelines [Internet] 2014:1–156. Available from: . Accessed 14 April 2020.
    1. Hinds WC. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. New York: John; Wiley & Sons; 2012.
    1. Yan Y, Li X, Tu J. Thermal effect of human body on cough droplets evaporation and dispersion in an enclosed space. Build Environ 2019; 148:96–106.
    1. Qian H, Zheng X. Ventilation control for airborne transmission of human exhaled bio-aerosols in buildings. J Thorac Dis 2018; 10:2295–304.
    1. Tang JW, Eames I, Li Y, et al. . Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. J Hosp Infect 2005; 61:283–6.
    1. MacIntyre CR, Wang Q, Cauchemez S, et al. . A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir Viruses 2011; 5:170–9.
    1. MacIntyre CR, Wang Q, Seale H, et al. . A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med 2013; 187:960–6.
    1. Radonovich LJ, Simberkoff MS, Bessesen MT, et al. . N95 respirators vs medical masks for preventing influenza among health care personnel. JAMA 2019; 322:824.
    1. Blachere FM, Lindsley WG, Pearce TA, et al. . Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009; 48:438–40.
    1. Guo Z-D, Wang Z-Y, Zhang S-F, et al. . Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis 2020; 26. doi:
    1. Ong SWX, Tan YK, Chia PY, et al. . Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020. doi:
    1. MacIntyre CRCR, Chughtai AAAA, Rahman B, et al. . The efficacy of medical masks and respirators against respiratory infection in healthcare workers. Influenza Other Respi Viruses 2017; 11:511–7.
    1. MacIntyre CR, Chughtai AA, Seale H, Richards GA, Davidson PM. Uncertainty, risk analysis and change for Ebola personal protective equipment guidelines. Int J Nurs Stud 2015; 52:899–903.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다